Request Deal Involvement

Patient Square-backed Enavate Sciences led a $100m Series B funding round in CAMP4 Therapeutics.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

ScientPR

pr advisors

ScientPR

Ropes & Gray

legal advisors

Ropes & Gray

or

Principals

PATIENT SQUARE CAPITAL

bidder

PATIENT SQUARE CAPITAL

NORTHPOND VENTURES

bidder

NORTHPOND VENTURES

ENAVATE SCIENCES

bidder

ENAVATE SCIENCES

GAINGELS

bidder

GAINGELS

KRAFT GROUP

bidder

KRAFT GROUP

5AM VENTURES LLC

bidder

5AM VENTURES LLC

CAMP4 THERAPEUTICS

target

CAMP4 THERAPEUTICS

ANDREESSEN HOROWITZ LLC (A16Z)

bidder

ANDREESSEN HOROWITZ LLC (A16Z)

POLARIS PARTNERS

bidder

POLARIS PARTNERS

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Patient Square-backed Enavate Sciences led a $100m Series B funding round in CAMP4 Therapeutics.